Search results
Can a vegan diet, exercise and meditation halt Alzheimer's disease?
USA Today· 16 hours agoPeople with early-stage Alzheimer's disease may be able to slow their cognitive decline through diet...
Is there genetic testing for Alzheimer’s disease?
St. Louis Post-Dispatch· 1 day agoWhile it is true that Alzheimer’s can be inherited, there are other factors that affect the possibility of a person developing the disease. There are two...
Ohio State creates database for Alzheimer’s genetics research
The Cleveland Plain Dealer· 1 hour agoScientists at The Ohio State University Wexner Medical Center have created a searchable database to...
US FDA staff raise no major concerns about Eli Lilly Alzheimer's drug
Reuters via Yahoo News· 2 days agoAn FDA analysis of trial data for Eli Lilly's experimental Alzheimer's drug donanemab released on...
Eli Lilly’s Alzheimer’s drug to face safety, dosing scrutiny from FDA advisers
Market Watch· 13 hours agoThere was no comparison group to show outcomes in similar patients if they had continued treatment,...
‘A study to give us hope’: Lifestyle changes improve Alzheimer’s symptoms for some
CNN via Yahoo News· 12 hours agoFollowing a vegan diet, reducing stress, exercising and sharing feelings with others helped people...
These 5 lifestyle changes improved brain function for those with early Alzheimer’s
Fortune via Yahoo Finance· 9 hours agoMany people fear the physical and cognitive declines associated with aging, for good reason....
The 25 Best New Movies Streaming in June 2024
The Wrap via Yahoo News· 8 hours agoUsing home videos and interviews with Mel Brooks, Alan Alda, Carol Kane, Dick Cavett and Wilder’s wife, “Remembering ...
FDA Staff Proposes Narrow Approval for Lilly’s Alzheimer’s Drug
Bloomberg· 2 days agoUS drug regulatory staffers are considering a more targeted approval for Eli Lilly & Co.’s...
Eli Lilly's Alzheimer's Drug, Donanemab Faces FDA's Adcomm Vote Next Week On Data, Risk Profile
Benzinga via Yahoo Finance· 1 day agoIn March last year, Eli Lilly released the results of the TRAILBLAZER-ALZ 2 Phase 3 study of...